A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription
about
A transcription map of the 6p22.3 reading disability locus identifying candidate genesStrong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia.T cell avidity and tumor recognition: implications and therapeutic strategies.Database of T cell-defined human tumor antigens: the 2013 updateRegulation of cilium length and intraflagellar transport by the RCK-kinases ICK and MOK in renal epithelial cellsSense-antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science.Identification and characterization of 9D7, a novel human protein overexpressed in renal cell carcinoma.A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis.An antigenic peptide produced by reverse splicing and double asparagine deamidationIdentifying source proteins for MHC class I-presented peptides.Self peptides and the peptidic self.Multiple pathways to tumor immunity and concomitant autoimmunity.Towards patient-specific tumor antigen selection for vaccination.Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3' untranslated region of TRIT1.Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.Update on vaccine development for renal cell cancer.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Inhibition of beta-amyloid aggregation and neurotoxicity by complementary (antisense) peptides.Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.Human Tumor Antigens and Cancer Immunotherapy.Antisense translates into sense.An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes.+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.
P2860
Q21266625-215E83D2-E472-41B0-8B7B-A15A81BA95B0Q24531462-74E4188D-306C-4AAA-A032-CB5BE083D461Q24815775-F8A05B70-0ADC-46EC-B2DE-88DED5C227F2Q27022422-F2CB33BE-498A-4E15-9D45-6F961F554D1BQ27343412-049B77BB-E1A8-4F3A-A5D7-3503C4A2CC1FQ30370722-A30B25D8-3FAB-4D77-B188-835E7465C101Q30790800-40AFFC59-2205-40EE-BFFB-95CE6F6228F0Q30865419-ADC29F02-770E-4BF3-A0ED-CE1175688656Q33914551-170FA68B-83D2-4F30-8F19-9FBE05DC19C1Q34192290-BF3CABD3-A45F-4ADD-A24A-43D2396544B2Q34553385-1DE977A6-213F-48A7-92DC-0959D420B3FAQ34560516-91D3192C-3632-4180-9656-481C075681A2Q35005947-EC6F75F7-D856-49E4-A923-C5C1ADF85A11Q35005960-509E5954-91EF-4A07-B9F5-316F52F62278Q35146595-B9E2990E-8938-494B-946C-C59A409D9D2DQ35160569-1283956A-A4F6-4100-9239-44EBBE0F2215Q36664234-8995394A-92A2-4A2F-9E74-98F22D56C094Q36871710-0F747F51-736C-4263-8D6E-F5D920C4A28DQ36989720-3E5FDE25-F67A-459D-8308-5DC4146AA2F0Q37851050-FEA9E006-879A-4BDA-8FCB-3F3128C94AD5Q40115555-181CCADD-DE73-431F-8FDF-33F19A69151FQ40361635-25C1A8E6-F1A4-4B0C-8A5E-7F920AC002D3Q41533232-D10717A9-F391-4B6F-B067-FC02F28F6BC0Q41932875-ACC6E54C-B3CD-4602-81DE-DD89417AF463Q42058413-3484E369-759D-4873-903B-BC2DF576712BQ42080041-7F429EF2-22A0-4E78-AA7E-001C574595C5Q43557973-23920809-F439-4B22-94D3-64EFBC64209DQ45284671-DBCEAA49-0402-47A5-AFB2-B45834DDFA6FQ47797670-2813F8B5-8029-4B74-9671-457AC859B53E
P2860
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A new antigen recognized by cy ...... m reverse strand transcription
@ast
A new antigen recognized by cy ...... m reverse strand transcription
@en
A new antigen recognized by cy ...... m reverse strand transcription
@en-gb
A new antigen recognized by cy ...... m reverse strand transcription
@nl
type
label
A new antigen recognized by cy ...... m reverse strand transcription
@ast
A new antigen recognized by cy ...... m reverse strand transcription
@en
A new antigen recognized by cy ...... m reverse strand transcription
@en-gb
A new antigen recognized by cy ...... m reverse strand transcription
@nl
prefLabel
A new antigen recognized by cy ...... m reverse strand transcription
@ast
A new antigen recognized by cy ...... m reverse strand transcription
@en
A new antigen recognized by cy ...... m reverse strand transcription
@en-gb
A new antigen recognized by cy ...... m reverse strand transcription
@nl
P2093
P2860
P921
P356
P1476
A new antigen recognized by cy ...... m reverse strand transcription
@en
P2093
B J Van Den Eynde
M Probst-Kepper
P Weynants
P2860
P304
P356
10.1084/JEM.190.12.1793
P407
P577
1999-12-20T00:00:00Z